226 related articles for article (PubMed ID: 12746758)
21. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
[TBL] [Abstract][Full Text] [Related]
22. Anticardiolipin antibodies in autoimmune thyroid disease.
Díez JJ; Doforno RA; Iglesias P; Sastre J; Gómez-Pan A; Borbujo J
J Clin Lab Immunol; 1993; 40(3):125-34. PubMed ID: 7877152
[TBL] [Abstract][Full Text] [Related]
23. Ten-year follow-up study of thyroid function in euthyroid patients with simple goiter or Hashimoto's thyroiditis.
Sato A; Aizawa T; Koizumi Y; Komiya I; Ichikawa K; Takemura Y; Yamada T
Intern Med; 1995 May; 34(5):371-5. PubMed ID: 7647404
[TBL] [Abstract][Full Text] [Related]
24. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
[TBL] [Abstract][Full Text] [Related]
25. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
26. HLA antigens in autoimmune thyroid diseases.
Arch Intern Med; 1978 Apr; 138(4):567-70. PubMed ID: 580355
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study.
Yu O; Bohlke K; Hanson CA; Delaney K; Rees TG; Zavitkovsky A; Ray P; Mullooly J; Black SB; Benson P; Thompson WW; Davis RL; Jackson LA
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):736-45. PubMed ID: 17192842
[TBL] [Abstract][Full Text] [Related]
29. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
[TBL] [Abstract][Full Text] [Related]
30. Decrease of peripheral large granular lymphocytes in Graves' disease.
Iwatani Y; Amino N; Kabutomori O; Mori H; Tamaki H; Motoi S; Izumiguchi Y; Miyai K
Clin Exp Immunol; 1984 Jan; 55(1):239-44. PubMed ID: 6546360
[TBL] [Abstract][Full Text] [Related]
31. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E
J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
[TBL] [Abstract][Full Text] [Related]
32. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease.
Morishita E; Hashimoto T; Asakura H; Saito M; Yamazaki M; Aoshima K; Yoshida T; Kato H; Matsuda T
Thromb Haemost; 1998 May; 79(5):919-23. PubMed ID: 9609221
[TBL] [Abstract][Full Text] [Related]
33. [Clinical validity of anti-thyroperoxidase antibody and anti-thyroglobulin antibody].
Lian XL; Bai Y; Sun ML; Guo ZS; Dai WX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):677-81. PubMed ID: 15663231
[TBL] [Abstract][Full Text] [Related]
34. [Two-center evaluation of eight kits for antithyroid peroxidase autoantibodies determinations].
d'Herbomez M; Sapin R; Gasser F; Schlienger JL; Wémeau JL
Ann Biol Clin (Paris); 2000; 58(4):445-51. PubMed ID: 10932045
[TBL] [Abstract][Full Text] [Related]
35. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
Hu YM; Liu W; Lu GH
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
[TBL] [Abstract][Full Text] [Related]
36. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.
Iitaka M; Miura S; Yamanaka K; Kawasaki S; Kitahama S; Kawakami Y; Kakinuma S; Oosuga I; Wada S; Katayama S
J Clin Endocrinol Metab; 1998 Nov; 83(11):3908-12. PubMed ID: 9814467
[TBL] [Abstract][Full Text] [Related]
37. [Determination of serum neopterin levels in patients with autoimmune thyroid diseases].
Balázs C; Türke B; Vámos A
Orv Hetil; 2012 Jul; 153(29):1127-31. PubMed ID: 22805038
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of pregnancy associated alpha 2-glycoprotein (alpha 2-PAG) during pregnancy in autoimmune thyroid disease: relationship to disease activity.
Scott RM; How J; Gerrie LM; Khir AS; Bewsher PD; Horne CH; Thomson AW
Clin Exp Immunol; 1985 Mar; 59(3):564-70. PubMed ID: 3838711
[TBL] [Abstract][Full Text] [Related]
39. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases.
Bradly DP; Reddy V; Prinz RA; Gattuso P
Surgery; 2009 Dec; 146(6):1099-104. PubMed ID: 19958937
[TBL] [Abstract][Full Text] [Related]
40. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis.
Pani MA; Regulla K; Segni M; Hofmann S; Hüfner M; Pasquino AM; Usadel KH; Badenhoop K
J Clin Endocrinol Metab; 2002 Jun; 87(6):2564-7. PubMed ID: 12050214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
